DE60115203D1 - Beschichtete implantate - Google Patents

Beschichtete implantate

Info

Publication number
DE60115203D1
DE60115203D1 DE60115203T DE60115203T DE60115203D1 DE 60115203 D1 DE60115203 D1 DE 60115203D1 DE 60115203 T DE60115203 T DE 60115203T DE 60115203 T DE60115203 T DE 60115203T DE 60115203 D1 DE60115203 D1 DE 60115203D1
Authority
DE
Germany
Prior art keywords
polymer
stent
meth
acrylate
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115203T
Other languages
English (en)
Other versions
DE60115203T2 (de
Inventor
Gerald Hughes
Terrence Albert Vick
Jin Hai Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocompatibles UK Ltd
Original Assignee
Biocompatibles UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibles UK Ltd filed Critical Biocompatibles UK Ltd
Application granted granted Critical
Publication of DE60115203D1 publication Critical patent/DE60115203D1/de
Publication of DE60115203T2 publication Critical patent/DE60115203T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31855—Of addition polymer from unsaturated monomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
DE60115203T 2000-01-24 2001-01-24 Beschichtete implantate Expired - Lifetime DE60115203T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00300509 2000-01-24
PCT/GB2001/000281 WO2001052915A1 (en) 2000-01-24 2001-01-24 Coated implants
EP00300509 2001-01-24

Publications (2)

Publication Number Publication Date
DE60115203D1 true DE60115203D1 (de) 2005-12-29
DE60115203T2 DE60115203T2 (de) 2006-08-03

Family

ID=8172662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115203T Expired - Lifetime DE60115203T2 (de) 2000-01-24 2001-01-24 Beschichtete implantate

Country Status (7)

Country Link
US (2) US6746686B2 (de)
EP (1) EP1250164B1 (de)
JP (1) JP5000826B2 (de)
AT (1) ATE310542T1 (de)
AU (1) AU2001228653A1 (de)
DE (1) DE60115203T2 (de)
WO (1) WO2001052915A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20040254635A1 (en) * 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
ATE319421T1 (de) * 1999-05-27 2006-03-15 Biocompatibles Uk Ltd Lokale arzneistoffabgabe
PT1328213E (pt) 2000-10-16 2005-10-31 Conor Medsystems Inc Dispositivo medico expansivel para a administracao de um agente benefico
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US20040073294A1 (en) * 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20040204756A1 (en) * 2004-02-11 2004-10-14 Diaz Stephen Hunter Absorbent article with improved liquid acquisition capacity
US7682669B1 (en) * 2001-07-30 2010-03-23 Advanced Cardiovascular Systems, Inc. Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
US20040249443A1 (en) * 2001-08-20 2004-12-09 Shanley John F. Expandable medical device for treating cardiac arrhythmias
US20040137066A1 (en) * 2001-11-26 2004-07-15 Swaminathan Jayaraman Rationally designed therapeutic intravascular implant coating
US20030050648A1 (en) 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
US6592594B2 (en) 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
AU2003210787B2 (en) 2002-02-01 2009-04-23 Medinol Ltd. Phosphorus-containing compounds & uses thereof
US20060235432A1 (en) * 2002-02-21 2006-10-19 Devore Lauri J Intra-bronchial obstructing device that controls biological interaction with the patient
US6929637B2 (en) * 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20030216769A1 (en) 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US7758636B2 (en) * 2002-09-20 2010-07-20 Innovational Holdings Llc Expandable medical device with openings for delivery of multiple beneficial agents
AU2003291470A1 (en) * 2002-11-08 2004-06-03 Innovational Holdings, Llc Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
CA2513721C (en) * 2002-11-08 2013-04-16 Conor Medsystems, Inc. Method and apparatus for reducing tissue damage after ischemic injury
US20050079199A1 (en) * 2003-02-18 2005-04-14 Medtronic, Inc. Porous coatings for drug release from medical devices
US20050010170A1 (en) * 2004-02-11 2005-01-13 Shanley John F Implantable medical device with beneficial agent concentration gradient
EP2272544A1 (de) * 2003-03-28 2011-01-12 Conor Medsystems, Inc. Implantierbare medizinische Vorrichtung enthaltend eine therapeutische Substanz in einem Konzentrationsgradient.
US7100616B2 (en) 2003-04-08 2006-09-05 Spiration, Inc. Bronchoscopic lung volume reduction method
US7533671B2 (en) 2003-08-08 2009-05-19 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
WO2005027991A1 (en) * 2003-09-19 2005-03-31 Cambridge University Technical Services Ltd Orthopaedic devices
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20050100577A1 (en) * 2003-11-10 2005-05-12 Parker Theodore L. Expandable medical device with beneficial agent matrix formed by a multi solvent system
WO2005075003A1 (en) * 2004-01-21 2005-08-18 Medtronic Vascular Inc. Implantable medical devices for treating or preventing restenosis
US20050208093A1 (en) 2004-03-22 2005-09-22 Thierry Glauser Phosphoryl choline coating compositions
US20050287287A1 (en) * 2004-06-24 2005-12-29 Parker Theodore L Methods and systems for loading an implantable medical device with beneficial agent
GB2420976B (en) * 2004-11-19 2006-12-20 Zvi Finkelstein Therapeutic implant
US9101949B2 (en) 2005-08-04 2015-08-11 Eilaz Babaev Ultrasonic atomization and/or seperation system
US7896539B2 (en) 2005-08-16 2011-03-01 Bacoustics, Llc Ultrasound apparatus and methods for mixing liquids and coating stents
US20070048349A1 (en) * 2005-08-29 2007-03-01 Bausch & Lomb Incorporated Surface-modified medical devices and methods of making
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US8568764B2 (en) * 2006-05-31 2013-10-29 Advanced Cardiovascular Systems, Inc. Methods of forming coating layers for medical devices utilizing flash vaporization
US7997226B2 (en) * 2006-10-18 2011-08-16 Innovational Holdings Llc Systems and methods for producing a medical device
WO2008070604A1 (en) * 2006-12-04 2008-06-12 Cree Led Lighting Solutions, Inc. Lighting device and lighting method
EP2157976A4 (de) * 2007-04-19 2012-03-07 Univ Massachusetts Medical Auf wärme ansprechende polymersiloxane, zusammensetzungen und verfahren und anwendungen im zusammenhang damit
US8802184B2 (en) * 2007-05-30 2014-08-12 Abbott Cardiovascular Systems Inc. Medical devices containing biobeneficial particles
US7753285B2 (en) 2007-07-13 2010-07-13 Bacoustics, Llc Echoing ultrasound atomization and/or mixing system
US7780095B2 (en) 2007-07-13 2010-08-24 Bacoustics, Llc Ultrasound pumping apparatus
US8043301B2 (en) 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
CN101868199B (zh) 2007-10-12 2016-04-06 斯波瑞申有限公司 阀装载器方法、系统以及设备
EP2268332B1 (de) * 2008-04-09 2019-01-16 Aachen Scientific International PTE. LTD. Verfahren zur erzeugung einer bioaktiven oberfläche auf einer endoprothese oder auf dem ballon eines ballonkatheters
ES2921527T3 (es) 2009-06-03 2022-08-29 Forsight Vision5 Inc Administración de fármaco en segmento anterior
EP2380602B1 (de) * 2010-04-14 2015-04-22 Hans Kosak Kunststoffe enthaltend Nukleinsäuren in komplexierter Form und Verfahren zu deren Herstellung
WO2013128633A1 (ja) * 2012-03-02 2013-09-06 日油株式会社 コンタクトレンズ用ケア製剤及びパッケージング溶液
US9295747B2 (en) 2010-10-20 2016-03-29 Nof Corporation Contact lens care preparation and packaging solution
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
WO2013053483A1 (de) 2011-10-11 2013-04-18 Secutech International Pte. Ltd. Verfahren zur herstellung von kunststoffen enthaltend nukleinsäuren in komplexierter form
PT2911623T (pt) 2012-10-26 2019-11-21 Forsight Vision5 Inc Sistema oftálmico para libertação prolongada de fármaco no olho
JP6111052B2 (ja) * 2012-11-22 2017-04-05 国立大学法人 東京大学 耐汚染性を付与するための水溶性表面処理剤、および表面処理方法
CN105283521B (zh) * 2013-05-27 2018-05-11 Jsr株式会社 由无机材料构成的表面用的表面处理剂、表面被改性的器具和装置、该器具和装置的制造方法
EP3000842B1 (de) 2013-06-20 2019-11-06 Sumitomo Rubber Industries, Ltd. Oberflächenmodifizierungsverfahren und oberflächenmodifizierungskörper
JP6008213B2 (ja) * 2014-08-06 2016-10-19 リューベン，アレクサンダー 体内プロテーゼ上又はバルーンカテーテルのバルーン上の生体活性表面の製造方法
JP6371165B2 (ja) * 2014-09-02 2018-08-08 住友ゴム工業株式会社 金属医療用具
EP3283004A4 (de) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Augeneinsatzzusammensetzung aus einem semikristallinen oder kristallinen pharmazeutischen wirkstoff
JP6613692B2 (ja) 2015-08-03 2019-12-04 住友ゴム工業株式会社 表面改質方法及び表面改質弾性体
US10730983B2 (en) 2016-06-13 2020-08-04 Massachusetts Institute Of Technology Biocompatible coatings and hydrogels for reducing foreign body response and fibrosis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674192A (en) 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
EP0593561B1 (de) 1991-07-05 2000-03-22 Biocompatibles Limited Polymere oberflächenbeschichtungszusammensetzungen
ATE196303T1 (de) 1991-08-08 2000-09-15 Biocompatibles Ltd Polymere oberflächenbeschichtungszusammensetzung
US5342621A (en) 1992-09-15 1994-08-30 Advanced Cardiovascular Systems, Inc. Antithrombogenic surface
KR100316205B1 (ko) 1993-01-07 2002-04-24 아브람 엠. 골드핑거 평활근세포의증식을조절하기위한c-myc의안티센스억제
CA2184375C (en) * 1994-03-18 2006-05-02 Sergei M. Gryaznov Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
US6090618A (en) 1996-10-07 2000-07-18 Arch Development Corporation DNA constructs and viral vectors comprising a smooth muscle promoter
US5876433A (en) 1996-05-29 1999-03-02 Ethicon, Inc. Stent and method of varying amounts of heparin coated thereon to control treatment
AU3308597A (en) 1996-06-14 1998-01-07 Kriton Medical, Inc. Methods and devices for reducing angina, enhancing myocardial perfusion and increasing cardiac function
GB9624130D0 (en) 1996-11-20 1997-01-08 Biocompatibles Ltd Biocompatible compositions
DE69831938T2 (de) 1997-02-20 2006-07-06 Cook Inc., Bloomington Beschichtetes, implantierbares medizinisches geräte
DE19713214A1 (de) * 1997-03-28 1998-12-10 Ruebben Alexander Dr Med Covered Stent zur verlängerten Offenhaltung von Hohlorganen oder der Behandlung von Gefäßaneurysmen
US6776792B1 (en) 1997-04-24 2004-08-17 Advanced Cardiovascular Systems Inc. Coated endovascular stent
US6221425B1 (en) * 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
ATE219693T1 (de) * 1998-04-27 2002-07-15 Surmodics Inc Bioaktive wirkstoffe freisetzende beschichtungen
ATE319421T1 (de) 1999-05-27 2006-03-15 Biocompatibles Uk Ltd Lokale arzneistoffabgabe

Also Published As

Publication number Publication date
AU2001228653A1 (en) 2001-07-31
US20030086957A1 (en) 2003-05-08
US20040197585A1 (en) 2004-10-07
JP5000826B2 (ja) 2012-08-15
EP1250164B1 (de) 2005-11-23
ATE310542T1 (de) 2005-12-15
WO2001052915A1 (en) 2001-07-26
DE60115203T2 (de) 2006-08-03
EP1250164A1 (de) 2002-10-23
JP2003520107A (ja) 2003-07-02
US6746686B2 (en) 2004-06-08

Similar Documents

Publication Publication Date Title
DE60115203D1 (de) Beschichtete implantate
GB0100761D0 (en) Drug delivery from stents
WO1998029095A3 (en) Sustained release cisapride mini-tablet formulation
EP0636366A3 (de) Mit wässrigen Dispersionen aus Acrylpolymere umgehüllte Formulierungen zur kontrollierten Freigabe
WO2001030408A3 (en) Adhesive composition over a bioactive polymerization initiator
CA2236182A1 (en) Drug-releasing coatings for medical devices
EP1166866A3 (de) Eingekapselte Chemikalien zur Verwendung in zeitverzögerter und kontrollierter Abgabe
ATE391496T1 (de) Geschmacksmaskierte pharmazeutische formulierungen
RU92004344A (ru) Устойчивые лекарственные формы с регулируемым выделением, имеющие акриловые полимерные покрытия, и способ их получения
ES2143301T3 (es) Composiciones biocompatibles.
AU4941400A (en) Local drug delivery
BR0016828A (pt) Polìmeros superabsorventes
DE69635481D1 (de) Auslösbares wirkstoffabgabesystem
ATE345781T1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
DE69832092D1 (de) VERBESSERTE HMG CoA REDUKTASE-INHIBITOR FORMULIERUNG MIT VERLÄNGERTER FREISETZUNG
NO982764L (no) Oppfinnelse og anordning for transdermal anordning for avgivelse av flurbiprofen
EP1076239A3 (de) Beschichtung mit quervernetzten hydrophilen Polymeren
EP0640337A3 (de) Arzneimittel mit gesteuertem Beginn und gesteuerter Rate der Freisetzung
ES2172664T3 (es) Punta de aplicador impregnada.
WO2002024174A3 (en) Sustained release composition containing clarithromycin
CY1110409T1 (el) Συνθεσεις ομοιοπολικως-συνδεδεμενης υδροφιλης επικαλυψης για εμφυτευματα
DE69411016D1 (de) Polymeroberflächenbeschichtungszusammensetzung
CA2361602A1 (fr) Mousse coiffante longue tenue
ES2185911T3 (es) Composiciones farmaceuticas que contienen polimeros de ortoester tamponados.
BR0315027A (pt) Polìmeros para proteger materiais de danos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition